Country: Írland
Tungumál: enska
Heimild: HPRA (Health Products Regulatory Authority)
SODIUM CHLORIDE
B. Braun Medical, SA
QB05BB01
SODIUM CHLORIDE
0.9 g/100ml
Solution for Infusion
POM
Bovine, Canine, Caprine, Equine - Food, Feline, Ovine, Porcine
Electrolytes
Electrolytes
Authorised
2013-10-04
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Sodium Chloride 0.9 g/100 ml B. Braun Vet Care solution for infusion for cattle, horse, sheep, goat, pig, dog and cat 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Solution for infusion Clear, colourless aqueous solution, free of particles in suspension 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, horse, sheep, goat, pig, dog and cat 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES The veterinary medicinal product is used in the target species in the following situations: - States of dehydration and hypovolaemia - Deficiency of sodium (hyponatraemia) and chloride (hypochloraemia) - Hypochloraemic alkalosis management - Vehicle solution for compatible drugs - External use for wound irrigation and moistening of compresses 4.3 CONTRAINDICATIONS Do not use in animals with: - Hypertonic dehydration - Hypernatraemia - Hyperchloraemia - Hyperhydration - Acidosis - Syndrome of oedema and ascites - In cases when sodium restriction are indicated Each of 100 ml of solution for infusion contains: ACTIVE SUBSTANCE: Sodium chloride 0.9 g Electrolyte concentration Sodium 154 mmol/l Chloride 154 mmol/l Theoretical osmolarity 308 mOsm/l EXCIPIENTS: For the full list of excipients, see section 6.1. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 16/09/2015_ _CRN 7021662_ _page number: 1_ 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Not applicable. 4.5 SPECIAL PRECAUTIONS FOR USE I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS Use with caution in animals with cardiac or renal impairment as sodium overload may occur. The maximum infusion rate should be decreased in the presence of cardiac, renal and pulmonary disease Lestu allt skjalið